Actinogen Medical Ltd. | |
Stock Exchange | Australian Stock Exchange |
EPS |
AUD0.01 |
Market Cap |
AUD12.71 M |
Shares Outstanding |
1.12 B |
Public Float |
- |
Address |
109 Pitt Street Sydney New South Wales (NSW) 2000 Australia |
Employees | - |
Website | http://www.actinogen.com.au |
Updated | 07/08/2019 |
Actinogen Medical Ltd. is a clinical stage Australian biotechnology company, which focuses on the development of novel treatments for Alzheimer's disease and other major age-related neurodegenerative disorders. The company was founded by David Keast on March 23, 1999 and is headquartered in West Perth, Australia. . |